- Filed
- Apr 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 1, 2025 | 14.92M sh |
| Capex | FY 2024 · Dec 31, 2023 | $102K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $20.01M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $18.71M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $55.43M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $64.48M |
| Current Assets | FY 2024 · Dec 31, 2023 | $49.29M |
| Total Assets | FY 2024 · Dec 31, 2023 | $106.08M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $2.08 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $2.08 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $3.13M |
| Net Income | FY 2024 · Dec 31, 2023 | $31.01M |
| Operating Income | FY 2024 · Dec 31, 2023 | $36.39M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2023 | $353.95M |
| Revenue | FY 2024 · Dec 31, 2023 | $396.05M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $10.59M |